doi: 10.1111/j.1365-2672.2006.03084.x 59 PylkasAMJunejaLRSlavinJL
Hair loss is usually due to rapid weight loss or low nutrition, though some reports suggest a possible link between GLP-1s and alopecia
It all starts with one prompt in Claude Code: What Nimble found: $52-94B market (2025), projected $132-185B by 2033 Eli Lilly became the first $1T healthcare company on tirzepatide momentum Novo Nordisk CEO replaced after CagriSema missed its target Pipeline: retatrutide (triple agonist, ~24% weight loss), orforglipron (first unrestricted oral), amycretin (next-gen) FDA cracking down on compounded semaglutide Hims & Hers stock collapsed Medicare Part D obesity coverage starting July 2026 40M new beneficiaries Result: 82 cross-linked wiki pages : 18 companies, 10 drugs, 10 clinical trials, 7 people, 6 markets, 5 regulatory events
Heine M, Fischer AW, Schlein C, Jung C, Straub LG, Gottschling K, et al
Frequently Asked Questions Can I stop tirzepatide cold turkey, or do I need to taper
And by the time the next Friday arrives, the cycle resets